Xylocydine, identified by its CAS number 685901-63-7, is a chemical compound that belongs to the class of local anesthetics. It is characterized by its ability to block nerve conduction, providing temporary loss of sensation in targeted areas. Xylocydine is typically used in medical applications, particularly in procedures requiring localized anesthesia. The compound exhibits a relatively rapid onset of action and a moderate duration of effect, making it suitable for various surgical and dental procedures. Its chemical structure includes an aromatic ring and an amide linkage, which are common features in local anesthetics, contributing to its pharmacological properties. Additionally, Xylocydine is generally well-tolerated, although, like other anesthetics, it may have potential side effects, including allergic reactions or systemic toxicity if administered improperly. As with any pharmaceutical agent, its use should be guided by appropriate medical protocols to ensure safety and efficacy.

Xylocydine is a novel Cdk inhibitor, which is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo. Xylocydine also strongly inhibits the activity of Cdk7 and Cdk9, in vitro as well as in cell cultures, that is temporally associated with apoptotic cell death in xylocydine-induced HCC cells.  Xylocydine can effectively suppress the growth of HCC xenografts in Balb/C-nude mice by preferentially inducing apoptosis in the xenografts, whereas the drug did not cause any apparent toxic effect on other tissues.Xylocydine is a good candidate for an anti-cancer drug for HCC therapy.

Xylocydine

685901-63-7: Xylocydine, identified by its CAS number 685901-63-7, is a chemical compound that belongs to the class of local anesthetics. It is characterized by its ability to block nerve conduction, providing temporary loss of sensation in targeted areas. Xylocydine is typically used in medical applications, particularly in procedures requiring localized anesthesia. The compound exhibits a relatively rapid onset of action and a moderate duration of effect, making it suitable for various surgical and dental procedures. Its chemical structure includes an aromatic ring and an amide linkage, which are common features in local anesthetics, contributing to its pharmacological properties. Additionally, Xylocydine is generally well-tolerated, although, like other anesthetics, it may have potential side effects, including allergic reactions or systemic toxicity if administered improperly. As with any pharmaceutical agent, its use should be guided by appropriate medical protocols to ensure safety and efficacy.

Xylocydine is a novel Cdk inhibitor that induces apoptosis in HCC, suppresses tumor growth, and is non-toxic to other tissues.

CAS 685901-63-7

Xylocydine

Xylocydine

Ref: TM-T68875